Ovoca Gold PLC
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It's lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporate… Read more
Ovoca Gold PLC (OVXA) - Net Assets
Latest net assets as of December 2023: €2.50 Million EUR
Based on the latest financial reports, Ovoca Gold PLC (OVXA) has net assets worth €2.50 Million EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.47 Million) and total liabilities (€967.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.50 Million |
| % of Total Assets | 72.12% |
| Annual Growth Rate | 3.84% |
| 5-Year Change | -89.51% |
| 10-Year Change | -88.86% |
| Growth Volatility | 48.02 |
Ovoca Gold PLC - Net Assets Trend (1987–2023)
This chart illustrates how Ovoca Gold PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ovoca Gold PLC (1987–2023)
The table below shows the annual net assets of Ovoca Gold PLC from 1987 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €2.50 Million | -67.24% |
| 2022-12-31 | €7.63 Million | -43.15% |
| 2021-12-31 | €13.43 Million | -27.61% |
| 2020-12-31 | €18.55 Million | -22.17% |
| 2019-12-31 | €23.84 Million | +15.56% |
| 2018-12-31 | €20.63 Million | -7.93% |
| 2017-12-31 | €22.40 Million | -4.55% |
| 2016-12-31 | €23.47 Million | +9.42% |
| 2015-12-31 | €21.45 Million | -4.49% |
| 2014-12-31 | €22.46 Million | -13.53% |
| 2013-12-31 | €25.97 Million | -46.58% |
| 2012-12-31 | €48.62 Million | -3.05% |
| 2011-12-31 | €50.15 Million | -11.62% |
| 2010-12-31 | €56.75 Million | +22.25% |
| 2009-12-31 | €46.42 Million | +21.52% |
| 2008-12-31 | €38.20 Million | -17.05% |
| 2007-12-31 | €46.05 Million | +49.39% |
| 2006-12-31 | €30.83 Million | +190.91% |
| 2005-12-31 | €10.60 Million | +140.08% |
| 2004-12-31 | €4.41 Million | -1.39% |
| 2003-12-31 | €4.48 Million | +41.69% |
| 2002-12-31 | €3.16 Million | -6.76% |
| 2001-12-31 | €3.39 Million | +7.93% |
| 2000-12-31 | €3.14 Million | -4.47% |
| 1999-12-31 | €3.29 Million | -0.09% |
| 1998-12-31 | €3.29 Million | +50.87% |
| 1997-12-31 | €2.18 Million | +12.72% |
| 1996-12-31 | €1.93 Million | -8.64% |
| 1995-12-31 | €2.12 Million | +17.94% |
| 1994-12-31 | €1.79 Million | -3.86% |
| 1993-12-31 | €1.87 Million | +66.40% |
| 1992-12-31 | €1.12 Million | +0.18% |
| 1991-12-31 | €1.12 Million | -31.67% |
| 1990-12-31 | €1.64 Million | -2.85% |
| 1989-12-31 | €1.69 Million | +64.91% |
| 1988-12-31 | €1.02 Million | +58.60% |
| 1987-12-31 | €645.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ovoca Gold PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1443600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €16.94 Million | 677.21% |
| Total Equity | €2.50 Million | 100.00% |
Ovoca Gold PLC Competitors by Market Cap
The table below lists competitors of Ovoca Gold PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ISIS PHARMACEUTICAL
BE:ISI
|
$638.61K |
|
Ribbon Acquisition Corp Rights
NASDAQ:RIBBR
|
$639.28K |
|
JULIUS BAER GRP N (JGE.SG)
STU:JGE
|
$639.51K |
|
Fold Holdings, Inc. Warrant
NASDAQ:FLDDW
|
$640.41K |
|
NEW YORK TIMES -A- (NYT.SG)
STU:NYT
|
$638.44K |
|
Gecina Nom
STU:GI6A
|
$638.28K |
|
Turbo Mech Bhd
KLSE:5167
|
$636.52K |
|
Brewbilt Brewing Co
PINK:BRBL
|
$635.90K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ovoca Gold PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 7,635,000 to 2,501,000, a change of -5,134,000 (-67.2%).
- Net loss of 4,702,000 reduced equity.
- Other factors decreased equity by 432,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-4.70 Million | -188.0% |
| Other Changes | €-432.00K | -17.27% |
| Total Change | €- | -67.24% |
Book Value vs Market Value Analysis
This analysis compares Ovoca Gold PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.34x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.93x to 0.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1988-12-31 | €0.01 | €0.01 | x |
| 1989-12-31 | €0.02 | €0.01 | x |
| 1990-12-31 | €0.02 | €0.01 | x |
| 1991-12-31 | €0.43 | €0.01 | x |
| 1992-12-31 | €0.43 | €0.01 | x |
| 1993-12-31 | €0.67 | €0.01 | x |
| 1994-12-31 | €0.54 | €0.01 | x |
| 1996-12-31 | €0.47 | €0.01 | x |
| 1997-12-31 | €0.49 | €0.01 | x |
| 1998-12-31 | €0.65 | €0.01 | x |
| 1999-12-31 | €0.60 | €0.01 | x |
| 2000-12-31 | €0.57 | €0.01 | x |
| 2001-12-31 | €0.59 | €0.01 | x |
| 2002-12-31 | €0.54 | €0.01 | x |
| 2003-12-31 | €0.65 | €0.01 | x |
| 2004-12-31 | €0.41 | €0.01 | x |
| 2005-12-31 | €0.48 | €0.01 | x |
| 2006-12-31 | €0.41 | €0.01 | x |
| 2007-12-31 | €0.59 | €0.01 | x |
| 2008-12-31 | €0.41 | €0.01 | x |
| 2009-12-31 | €0.51 | €0.01 | x |
| 2010-12-31 | €0.60 | €0.01 | x |
| 2011-12-31 | €0.53 | €0.01 | x |
| 2012-12-31 | €0.55 | €0.01 | x |
| 2013-12-31 | €0.30 | €0.01 | x |
| 2014-12-31 | €0.26 | €0.01 | x |
| 2015-12-31 | €0.26 | €0.01 | x |
| 2016-12-31 | €0.29 | €0.01 | x |
| 2017-12-31 | €0.27 | €0.01 | x |
| 2018-12-31 | €0.23 | €0.01 | x |
| 2019-12-31 | €0.27 | €0.01 | x |
| 2020-12-31 | €0.23 | €0.01 | x |
| 2021-12-31 | €0.16 | €0.01 | x |
| 2022-12-31 | €0.09 | €0.01 | x |
| 2023-12-31 | €0.03 | €0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ovoca Gold PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -188.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.39x
- Recent ROE (-188.00%) is below the historical average (-18.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1988 | -1.96% | 0.00% | 0.00x | 1.03x | €-122.30K |
| 1989 | -3.14% | 0.00% | 0.00x | 1.11x | €-221.70K |
| 1990 | -20.87% | 0.00% | 0.00x | 1.10x | €-505.90K |
| 1991 | -46.34% | 0.00% | 0.00x | 1.11x | €-631.00K |
| 1992 | -0.62% | 0.00% | 0.00x | 1.16x | €-119.20K |
| 1993 | -1.07% | 0.00% | 0.00x | 1.14x | €-206.70K |
| 1994 | -3.96% | 0.00% | 0.00x | 1.17x | €-250.50K |
| 1996 | -23.06% | 0.00% | 0.00x | 1.09x | €-639.40K |
| 1997 | -6.06% | 0.00% | 0.00x | 1.15x | €-350.00K |
| 1998 | -5.59% | 0.00% | 0.00x | 1.08x | €-512.90K |
| 1999 | -5.33% | 0.00% | 0.00x | 1.06x | €-503.60K |
| 2000 | -5.48% | 0.00% | 0.00x | 1.07x | €-485.90K |
| 2001 | -4.31% | 0.00% | 0.00x | 1.05x | €-484.80K |
| 2002 | -7.28% | 0.00% | 0.00x | 1.07x | €-545.90K |
| 2003 | -5.29% | 0.00% | 0.00x | 1.04x | €-684.60K |
| 2004 | -8.84% | 0.00% | 0.00x | 1.05x | €-831.40K |
| 2005 | -8.23% | 0.00% | 0.00x | 1.14x | €-1.78 Million |
| 2006 | -17.04% | 0.00% | 0.00x | 1.03x | €-8.33 Million |
| 2007 | -1.86% | 0.00% | 0.00x | 1.03x | €-5.46 Million |
| 2008 | -22.54% | 0.00% | 0.00x | 1.04x | €-12.43 Million |
| 2009 | 4.40% | 0.00% | 0.00x | 1.04x | €-2.60 Million |
| 2010 | -6.06% | 0.00% | 0.00x | 1.23x | €-9.11 Million |
| 2011 | 8.50% | 0.00% | 0.00x | 1.26x | €-752.30K |
| 2012 | -4.59% | 0.00% | 0.00x | 1.24x | €-7.09 Million |
| 2013 | -57.04% | 0.00% | 0.00x | 1.09x | €-17.41 Million |
| 2014 | -29.59% | 0.00% | 0.00x | 1.01x | €-8.89 Million |
| 2015 | -10.36% | 0.00% | 0.00x | 1.01x | €-4.37 Million |
| 2016 | -4.09% | 0.00% | 0.00x | 1.01x | €-3.31 Million |
| 2017 | -1.70% | 0.00% | 0.00x | 1.00x | €-2.62 Million |
| 2018 | -12.76% | 0.00% | 0.00x | 1.18x | €-4.20 Million |
| 2019 | -7.02% | 0.00% | 0.00x | 1.09x | €-3.80 Million |
| 2020 | -12.59% | 0.00% | 0.00x | 1.03x | €-4.19 Million |
| 2021 | -40.77% | 0.00% | 0.00x | 1.10x | €-6.82 Million |
| 2022 | -73.50% | 0.00% | 0.00x | 1.23x | €-6.38 Million |
| 2023 | -188.00% | 0.00% | 0.00x | 1.39x | €-4.95 Million |
Industry Comparison
This section compares Ovoca Gold PLC's net assets metrics with peer companies in the Biotechnology industry.
No peer company data available for comparison.